You really don't need both. There are enough people with rheumatoid arthritis or high cholesterol, for example, to have multiple blockbuster drugs that treat the diseases.
Keep Reading →
September 3 - News
Designed as a way to bring potentially life-changing drugs to pharmacy shelves faster than ever, the Food and Drug Administration Safety and Innovation Act, which passed last ...
Keep Reading →
September 3 - News
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...
Keep Reading →
September 3 - News
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...
Keep Reading →
August 31 - News
WASHINGTON (AP) -- Bottles of Tylenol sold in the U.S.
Keep Reading →
August 30 - News
A small section of the total Crohn's Disease) patient population is resistant to standard treatment options.
Keep Reading →
August 29 - News
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Keep Reading →
August 29 - News
Over the past several years, monoclonal antibodies have revolutionized cancer treatments.
Keep Reading →
August 28 - News
Several reports are circulating in the financial media that EPS growth for the S&P 500 member companies is slowing down to a trickle (or even poised for an outright drop) and ...
Keep Reading →
August 28 - News
The Procter & Gamble Company (NYSE:PG)'s recent earning reports weren't too impressive: they showed low growth in revenue and narrower profit margins.
Keep Reading →
August 28 - News
Shares of Perrigo Company (NYSE:PRGO), one of the world's largest health care suppliers, slid with the broader market on Aug.
Keep Reading →
August 27 - News
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors.
Keep Reading →
August 27 - Hedge Funds
NEW YORK (AP) -- The Procter & Gamble Company (NYSE:PG) gave former CEO Bob McDonald a pay package worth $15.9 million during his final full year at the helm of the world's largest...
Keep Reading →
August 23 - News
Shares of small biotech ChemoCentryx Inc (NASDAQ:CCXI) collapsed by 44% in early trading on Friday before paring the losses somewhat.
Keep Reading →
August 23 - Dividend Stocks, News
Editor’s Note: A previous version of this post incorrectly stated that Eli Lilly’s experimental drug solanezumab is a BACE inhibitor.
Keep Reading →
August 23 - News
Johnson & Johnson (NYSE:JNJ) completed its acquisition of privately held Aragon Pharmaceuticals earlier this week. Plans for the deal were first announced by J&J in June.
Keep Reading →
August 23 - News
Earlier this month, biotech powerhouse Celgene Corporation (NASDAQ:CELG) announced that the European Commission approved the combinational therapy of pomalidomide, known in the...
Keep Reading →
August 22 - News
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...
Keep Reading →
August 20 - News
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...
Keep Reading →
August 20 - News
The wealth-building power of compound interest will never cease to amaze me.
Keep Reading →
August 20 - News
It's no wonder that plenty of companies are developing diabetes drugs. There are more than 370 million people with diabetes worldwide.
Keep Reading →
August 20 - News
Since the Dow Jones Industrial Average (INDEXDJX:.DJI) closed on August 2 at 15,658, it has fallen nine of the 11 trading days and lost 648 points, or 4.13%.
Keep Reading →
August 19 - News
This could have been an enormously more difficult effort. I started out with the goal to identify the three best stocks in health care to buy and hold for years, even decades.
Keep Reading →
August 19 - News
It's not hard to locate a company willing to return at least some of its profit to shareholders, but finding one that will return a meaningful amount, and that shows the ability...
Keep Reading →
August 19 - News
At least the Food and Drug Administration is polite.
Keep Reading →
August 19 - News
Last week, the Trust for America's Health and the Robert Wood Johnson Foundation released their annual report (link opens a PDF to a 116-page report) on obesity trends in the ...
Keep Reading →
August 19 - News
Dividend investors would be wise to focus not just on a stock's current yield but also on the long-term growth potential of its dividends.
Keep Reading →
August 13 - News
Every month, I select one or more stocks that I'll be buying in real life for my Roth IRA.
Keep Reading →
August 12 - News
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
Keep Reading →
August 8 - News
The stock is up nearly 23% this year, even while companies like Johnson & Johnson (NYSE:JNJ) have disclosed lower-than-expected growth in surgical procedures.
Keep Reading →
August 7 - News
Only behind Johnson & Johnson (NYSE:JNJ) and well above Unilever plc (ADR) (NYSE:UL) in my performance chart, The Procter & Gamble Company (NYSE:PG) is among the best performing...
Keep Reading →
August 7 - News
A recent EvaluatePharma report estimated the market for prescribed drugs will increase at an annual rate of 3.8% to $895 billion from 2012 to 2018.
Keep Reading →
August 6 - News
Regardless of whether you're entirely for the Patient Protection and Affordable Care Act, vehemently against it, or fall somewhere in between, it's set to become the law of the...
Keep Reading →
August 6 - News
Diversification is an important characteristic of every portfolio. With diversity comes stability.
Keep Reading →
August 5 - News
Here is a statistic for you - the human population is rising by 200,000 people per day. For a lot of companies, that means 200,000 new potential customers.
Keep Reading →
August 5 - News
The biotechnology industry is one of the riskiest places to put your money. However, when companies get everything right, the fortunes made there are usually massive.
Keep Reading →
August 5 - News
During the past decade, healthcare has been one of the most stable and consistent performers among all industries.
Keep Reading →
August 5 - News
Maybe we should have guessed it from the Energizer Bunny's pink fur, but battery maker Energizer Holdings, Inc. (NYSE:ENR) is about to get more in touch with its feminine side...
Keep Reading →
August 2 - News
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) announced its second-quarter financial results on Thursday prior to the market open.
Keep Reading →
August 2 - News
Long-term income investors shouldn't be traders.
Keep Reading →
August 1 - News
Diabetes is one of the world's most dangerous and fastest-growing afflictions.
Keep Reading →
August 1 - News
There are many types of biotech companies out there with tremendous value. Today, I will focus on the ones that target prostate cancer.
Keep Reading →
August 1 - News
Beleaguered healthcare stock Intuitive Surgical, Inc. (NASDAQ:ISRG) recently announced a new, massive share repurchase authorization.
Keep Reading →
August 1 - News
Pharmacyclics, Inc. (NASDAQ:PCYC) has been a good company to invest in, especially if you had bought shares back in 2009 when it traded around $1 per share.
Keep Reading →
August 1 - News
Cystic fibrosis (CF), a genetic disorder that affects the lungs, the pancreas, liver, and intestine, is the second most common inherited disorder in the United States, after sickle...
Keep Reading →
August 1 - News
AstraZeneca plc (ADR) (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) announced last week that they are making another attempt at U.S.
Keep Reading →
July 30 - News
If you think that investing is simple, then just take a look at industrial giant General Electric Company (NYSE:GE)’s latest results.
Keep Reading →
July 29 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of the violation of Chinese laws wherein the company’s key officials have used around 700 agencies and firms for increasing...
Keep Reading →
July 29 - News
As the stock market creeps toward fresh all-time highs, it’s understandable for investors to get a little nervous.
Keep Reading →
July 29 - News
